Therapeutics News and Research

RSS

Researchers study epidemiology of Ebola Virus Disease to prevent future disease outbreaks

Now, researchers from Arizona State University and Georgia State University are trying to better understand the epidemiology and control of Ebola Virus Disease in order to alleviate suffering and prevent future disease outbreaks from reaching the catastrophic proportions of the current crisis.

9 Feb 2015

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

9 Feb 2015

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new "Program in Lung Healing," that will further the School's position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system.

9 Feb 2015

Overview of chlamydia trachomatis infections

RnRMarketResearch.com adds "Chlamydia Trachomatis Infections - Pipeline Review, H1 2015" research to its store.

8 Feb 2015

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.

8 Feb 2015

New compound may lead to development of potential therapeutics for neuropathic pain

A new compound discovered by a team of UC Davis investigators has potent actions against production of a chemical that which is implicated in the development of chronic pain following a peripheral nerve injury in the spinal cord.

7 Feb 2015

National #KnowBetterDoBetter movement comes to Los Angeles to end AIDS epidemic

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Los Angeles, CA and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

National #KnowBetterDoBetter movement comes to Houston to end AIDS epidemic

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Houston and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

National #KnowBetterDoBetter movement comes to Chicagoland to end AIDS epidemic

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Chicagoland and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with the greater knowledge and skills.

6 Feb 2015

BAI-led #KnowBetterDoBetter movement comes to Broward County to eliminate HIV/AIDS

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Broward County and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

Joyce and Don Massey Family Foundation supports U-M’s TBI care and research

A tragic accident 32 years ago forever altered the lives of an entire prominent Michigan auto industry family, as a beloved wife and mother suffered a devastating traumatic brain injury, or TBI.

6 Feb 2015

National #KnowBetterDoBetter movement comes to Bay Area to eliminate HIV and AIDS

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to the Bay Area and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

National #KnowBetterDoBetter movement comes to Charlotte, NC to eradicate HIV/AIDS

The national #KnowBetterDoBetter movement led by the Black AIDS Institute (BAI) is coming to Charlotte, NC and the message is loud and clear- we can end the AIDS epidemic if we fully engage non-medical workers on the frontline of the battle with greater knowledge and skills.

6 Feb 2015

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

An RTP-based pharmaceutical company with roots at the University of North Carolina at Chapel Hill has received $33 million in Series B venture capital funding to develop more effective and less toxic methods to treat patients with cancer.

6 Feb 2015

Crown Bioscience, NRCMM partner to develop new immune-oncology experimental cancer models

Crown Bioscience, Inc., a leading global drug discovery and development service company with its R&D centers across the globe has announced that a new partnership agreement has been reached with the National Resource Center for Mutant Mice and its commercial branch Nanjing Biotech Innovation Corporation, in Nanjing, Jiangsu Province, China.

6 Feb 2015

Recipients of The 2015 Protein Society Awards announced

The Protein Society, the premiere international society dedicated to supporting protein research, announces the winners of The 2015 Protein Society Awards. The awards will be conferred at the 29th Annual Symposium of The Protein Society (July 22-25, 2015, Barcelona, Spain).

5 Feb 2015

Antibodies used in research lab should be made by recombinant DNA technology, say authors

Antibodies are now established as therapeutics and indispensable in the research lab. In con-trast to high-quality therapeutics, commercial antibodies used in research often do not proper-ly function, as an international group of authors around Andreas Plückthun of UZH have warned.

5 Feb 2015

Therapeutics News and Research

Researchers study epidemiology of Ebola Virus Disease to prevent future disease outbreaks

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

Overview of chlamydia trachomatis infections

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

New compound may lead to development of potential therapeutics for neuropathic pain

National #KnowBetterDoBetter movement comes to Los Angeles to end AIDS epidemic

National #KnowBetterDoBetter movement comes to Houston to end AIDS epidemic

National #KnowBetterDoBetter movement comes to Chicagoland to end AIDS epidemic

BAI-led #KnowBetterDoBetter movement comes to Broward County to eliminate HIV/AIDS

Joyce and Don Massey Family Foundation supports U-M’s TBI care and research

National #KnowBetterDoBetter movement comes to Bay Area to eliminate HIV and AIDS

National #KnowBetterDoBetter movement comes to Charlotte, NC to eradicate HIV/AIDS

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

Crown Bioscience, NRCMM partner to develop new immune-oncology experimental cancer models

Recipients of The 2015 Protein Society Awards announced

Antibodies used in research lab should be made by recombinant DNA technology, say authors

Study could lead to potential drug treatment for fighting addiction

HIV science and treatment knowledge can end AIDS epidemic in the US

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

Understanding the DNA Damage Response in Innate Immunity eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News